Market Place
Sourcing Support
All News #Library
Others
Rubicon Enters Indian CNS Sector With Rs 175.92 Cr Arinna
16 Apr 2026 //
INDPHARMAPOST
Rubicon Research Acquires 85% Stake In Arinna Lifesciences
15 Apr 2026 //
EXPRESSPHARMA
General Atlantic Singapore Transfers 3.49M Rubicon Research Share
08 Oct 2025 //
EXPRESSPHARMA
Rubicon Research Secures Rs 140 Cr Investment From TIMF & 360 ONE
22 Sep 2025 //
EXPRESSPHARMA
Amansa Investments Completes ?250 Cr Pre-Ipo in Rubicon Research
14 Aug 2025 //
EXPRESSPHARMA
Rubicon Research buys Alkem’s Pithampur plant for ?149 crores
24 Jun 2025 //
EXPRESSPHARMA
Rubicon Research secures SEBI approval for IPO
06 Nov 2024 //
EXPRESSPHARMA
Rubicon Research Files Draft Papers For Rs 1,085-Cr IPO
02 Aug 2024 //
ECONOMICSTIMES
Kartha Pharmaceuticals, Inc. launches Baclofen USP Tablets in USA
21 Dec 2021 //
PRESS RELEASE
Rubicon Research acquires Satara facility of Meditab Specialities
10 Jul 2021 //
ECONOMIC TIMES
Rubicon Research acquires MeditabSpecialities’ facility in Satara, Maharashtra
09 Jul 2021 //
EXPRESS PHARMA
Rubicon acquires Meditab Specialities’ oral liquid and nasal inhalers facility
09 Jul 2021 //
PHARMABIZ
Research Co. Says Competitor Misappropriated Trade Secrets in DevP of Baclofen
31 Mar 2021 //
PRESS RELEASE
MilliporeSigma awards grants to Biotech companies
03 Jun 2019 //
BIOSPECTRUM
Everstone buys Mumbai-based drug tech firm Rubicon for Rs 220-crore
24 Oct 2016 //
ECONOMIC TIMES
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.